Is immunohistochemistry of BRAF V600E useful as a screening tool and during progression disease of melanoma patients?

被引：0
|
作者：
Laura Schirosi
Sabino Strippoli
Francesca Gaudio
Giusi Graziano
Ondina Popescu
Michele Guida
Giovanni Simone
Anita Mangia
机构：
[1] IRCCS Istituto Tumori “Giovanni Paolo II”,Functional Biomorphology Laboratory
[2] IRCCS Istituto Tumori “Giovanni Paolo II”,Medical Oncology Department
[3] IRCCS Istituto Tumori “Giovanni Paolo II”,Scientific Direction
[4] IRCCS Istituto Tumori “Giovanni Paolo II”,Pathology Department
来源：
BMC Cancer | / 16卷
关键词：
Melanoma; BRAF; VE1; Immunohistochemistry; Progression;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Management of V600E and V600K BRAF-Mutant Melanoma
    Alexandra M. Haugh
    Douglas B. Johnson
    Current Treatment Options in Oncology, 2019, 20
  • [32] Vemurafenib in Patients With BRAF V600E Mutation-Positive Advanced Melanoma
    Ravnan, Marcus C.
    Matalka, Mazen S.
    CLINICAL THERAPEUTICS, 2012, 34 (07) : 1474 - 1486
  • [33] Management of V600E and V600K BRAF-Mutant Melanoma
    Haugh, Alexandra M.
    Johnson, Douglas B.
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2019, 20 (11)
  • [34] Amelanotic primary dermal melanoma with V600E BRAF mutation
    Kabuto, Miho
    Fujimoto, Noriki
    Teramura, Kazuya
    Nakanishi, Takeshi
    Fujimura, Taku
    Manabe, Toshiaki
    Tanaka, Toshihiro
    DERMATOLOGICA SINICA, 2017, 35 (02) : 110 - 111
  • [35] Acquired and intrinsic BRAF inhibitor resistance in BRAF V600E mutant melanoma
    Fedorenko, Inna V.
    Paraiso, Kim H. T.
    Smalley, Keiran S. M.
    BIOCHEMICAL PHARMACOLOGY, 2011, 82 (03) : 201 - 209
  • [36] Prospective immunohistochemical analysis of BRAF V600E mutation in melanoma
    Ristimaki, A.
    Thiel, A.
    Moza, M.
    Kytola, S.
    Orpana, A.
    Jahkola, T.
    Hernberg, M.
    Virolainen, S.
    VIRCHOWS ARCHIV, 2014, 465 : S318 - S318
  • [37] Analysis of the BRAF V600E mutation in primary cutaneous melanoma
    Inumaru, J. S. S.
    Gordo, K. I. F.
    Fraga Junior, A. C.
    Silva, A. M. T. C.
    Leal, C. B. Q. S.
    Ayres, F. M.
    Wastowski, I. J.
    Borges, N. F.
    Saddi, V. A.
    GENETICS AND MOLECULAR RESEARCH, 2014, 13 (02) : 2840 - 2848
  • [38] A role for immunohistochemical detection of BRAF V600E in metastatic melanoma?
    Lade-Keller, J.
    Kristensen, L. S.
    Riber-Hansen, R.
    Guldberg, P.
    Hansen, L. L.
    Steiniche, T.
    Hager, H.
    APMIS, 2013, 121 : 7 - 7
  • [39] Braf V600E mutation in melanoma: translational current scenario
    Guadarrama-Orozco, J. A.
    Ortega-Gomez, A.
    Ruiz-Garcia, E. B.
    Astudillo-de la Vega, H.
    Meneses-Garcia, A.
    Lopez-Camarillo, C.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2016, 18 (09): : 863 - 871
  • [40] Reversible and adaptive resistance to BRAF(V600E) inhibition in melanoma
    Sun, Chong
    Wang, Liqin
    Huang, Sidong
    Heynen, Guus J. J. E.
    Prahallad, Anirudh
    Robert, Caroline
    Haanen, John
    Blank, Christian
    Wesseling, Jelle
    Willems, Stefan M.
    Zecchin, Davide
    Hobor, Sebastijan
    Bajpe, Prashanth K.
    Lieftink, Cor
    Mateus, Christina
    Vagner, Stephan
    Grernrum, Wipawadee
    Hofland, Ingrid
    Schlicker, Andreas
    Wessels, Lodewyk F. A.
    Beijersbergen, Roderick L.
    Bardelli, Alberto
    Di Nicolantonio, Federica
    Eggermont, Alexander M. M.
    Bernards, Rene
    NATURE, 2014, 508 (7494) : 118 - +
12345